2.55 USD
↗ 0.06 (2.41%)AT CLOSE (03:59 PM EDT)
NRX Pharmaceuticals, Inc. Common Stock
NRXPNASDAQ • USD
2.60
↗ 0.05 (1.96%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
2.60
↗ 0.05 (1.96%)
Market: CLOSED
NRX Pharmaceuticals, Inc. Common Stock (NRXP) is currently trading at $2.56. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (13811.8%) and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Oct 26, 2026.
Open?$2.48
High?$2.59
Low?$2.46
Prev. Close?$2.49
Volume?594.7K
Avg. Volume?743.8K
VWAP?$2.53
Rel. Volume?0.80x
Bid / Ask
Bid?$2.51 × 400
Ask?$2.61 × 100
Spread?$0.10
Midpoint?$2.56
Valuation & Ratios
Market Cap?110.4M
Shares Out?43.3M
Float?34.0M
Float %?93.9%
P/E Ratio?N/A
P/B Ratio?-649.44
EPS?-$0.54
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
Address
1201 ORANGE STREET
WILMINGTON, DE 19801
Phone: 484-254-6134
WILMINGTON, DE 19801
Phone: 484-254-6134
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?60
Short Sent.?10
Piotroski F-Score?0/9Weak
Altman Z-Score?-13.37Distress
Confidence?51%Low
Short InterestSqueeze Risk
Short % of Float?29.26%Squeeze Risk
Short Interest?9.9M
Days to Cover?16.8
Free Float34.0M
Avg Daily Volume593.6K
Settlement Date2026-10-15
Financial Health
Current Ratio?0.86Weak
Quick Ratio?0.86Weak
Cash Ratio?0.79Adequate
Debt/Equity?-2.42Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?-649.44CHEAP▾
S&P97
P/S?32.53HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-4.3CHEAP▾
S&P97
EV/Sales?24.79HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?13,811.8%STRONG▾
Peers50
S&P97
ROA?-68.7%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-20671000
Enterprise Value?$84.1M
Fundamentals ratios updated end of day